Inmune Bio INMB
NASDAQ INMB
$1.93 +0.00 (+0.26%)
As of: Oct 2, 2026 · 2:48 PM EDT

Inmune Bio (INMB) Depreciation & Amortization (CF) (2025 - 2026)

Updated

Inmune Bio (INMB) recorded Depreciation & Amortization (CF) of $100,000 in Q2 2026, up 92.3% from the prior quarter.

Analysis

Inmune Bio (INMB) Depreciation & Amortization (CF) (2025 - 2026) Analysis & Trends

For FY2025, Inmune Bio reported Depreciation & Amortization (CF) of $84,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Inmune Bio 53.92 Mn -38.33 Mn - 100,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 100,000.00
Mar 31, 2026 52,000.00
Dec 31, 2025 56,000.00
API Access

Inmune Bio Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=INMB&period=max&api_key=YOUR_API_KEY